Updates on the pathophysiology and therapies of chylous pleural effusion: A narrative review

Authors

  • Elmukhtar Habas
  • Kalifa Farfar
  • Almehdi Errayes
  • Gamal Alfitori
  • Hafedh Ghazouani
  • Ala Habas
  • Amnna Rayni
  • Aisha Aladab

DOI:

https://doi.org/10.32677/yjm.v2i3.4330

Keywords:

Chylous pleural effusion, Epidemiology of chylous effusion, Pathophysiology pf chylous pleural effusion, Management of chylous pleural effusion

Abstract

Chylous pleural effusion (CPE) is a milky pleural fluid that contains high levels of proteins, cholesterol, triglycerides, or chylomicrons. The main cause of CPE is disruption of the thoracic duct caused by traumatic or non-traumatic causes. High triglyceride, cholesterol, and/or chylomicron levels confirm the diagnosis. Recognizing the chyle leak site and underlying etiology is critical to the management of this clinical condition. There is no specific consensus on chylothorax treatment. However, a multidisciplinary (medical, surgical, and oncological) team approach is recommended.

Downloads

Download data is not yet available.

Downloads

Published

2023-12-19

Issue

Vol. 2 No. 3 (2023): September - December

Section

Review Articles

License

Copyright (c) 2023 Elmukhtar Habas, Kalifa Farfar, Almehdi Errayes, Gamal Alfitori, Hafedh Ghazouani, Ala Habas, Amnna Rayni, Aisha Aladab

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite

Updates on the pathophysiology and therapies of chylous pleural effusion: A narrative review. (2023). Yemen Journal of Medicine, 2(3), 145-150. https://doi.org/10.32677/yjm.v2i3.4330

Most read articles by the same author(s)